Systemic sclerosis, also known as scleroderma, is a rare autoimmune disease that can cause hardening and tightening of the skin, joint pain, fatigue, and in some cases, damage to internal organs. While it affects people of all backgrounds, Black patients often face more aggressive disease, worse symptoms, and higher rates of complications compared to other groups.
Despite these realities, Black patients are underrepresented in clinical research for systemic sclerosis. Lack of representation often leads to a gap in information and what researchers understand about how new treatments work in various groups.
The DAISY trial is studying an investigational medicine in patients with systemic sclerosis. Eligible patients must be at least 18 years of age, have been diagnosed with systemic sclerosis in the last six years, and are either not taking medication for it or receiving stable doses of certain medications. Click here to learn more about this research study.
Participating in DAISY is optional. You can change your mind and opt out at any time.
Systemic sclerosis may be rare, but its impact is felt deeply in Black communities. Studies show that Black patients are:
- More likely to be diagnosed at a younger age
- More likely to experience severe disease
- At higher risk of lung involvement, which can make breathing difficult
- Less likely to receive timely diagnosis and treatment
These disparities don’t just happen by chance. They are rooted in a variety of barriers to care, delayed diagnoses, and a lack of representation in research. Clinical trials promote quality care for those who qualify, regardless of their background.
What the DAISY Trial Is About
Clinical trials are part of the research process that explores experimental treatments and determines if they are safe and effective. There are specific criteria that the trial clinical team will review with you to see if DAISY is the right fit.
If you qualify and choose to take part, you won’t be left to navigate the journey alone. You’ll be supported by a team of medical staff who will answer your questions, monitor your health, and guide you step by step.
The results from this clinical trial could help people living with systemic sclerosis in the future.
Building Trust
It’s natural to have questions or doubts about clinical trials. There are built-in safety measures to ensure the clinical trial process is safe for those eligible to participate. Today’s trials have strict safety standards designed to protect participants.
Clinical trials are not just about science. Your experiences matter. Your participation helps researchers understand, and you contribute to closing the knowledge gap. You also help ensure that treatments are developed with the insight needed to make certain Black patients are represented in the data.
Take the Next Step
Living with systemic sclerosis can feel isolating, but you are not alone. Others are walking this path with you. Participation is always your choice.
If you or someone you love has been recently diagnosed with systemic sclerosis, the DAISY clinical trial may be an opportunity worth exploring. Click here to learn more, take the screener, and find out if the DAISY trial is right for you.
Content sponsored by AstraZeneca.
References:
